Variations in the Risk of New-Onset Diabetes Following COVID-19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population-Based Cohort Study in 42 Million People in England
COVID-19's link to new-onset diabetes is real but modest and temporary, mainly driven by pre-existing metabolic and socioeconomic factors.
This nation-scale linked EHR study (n=42 million, England) provides the most definitive evidence to date that COVID-19's contribution to new-onset T2D is real but modest and short-lived, with the dominant drivers being pre-existing metabolic and socioeconomic risk factors. The findings contextualize and appropriately downscale earlier concerns about COVID-19-triggered diabetes epidemics, with critical public health implications.
What the study was
- Study design
- Retrospective population-based cohort using linked NHS England electronic health records
- Population
- Adults ≥18 years, England (CVD-COVID-UK/COVID-IMPACT consortium); 12.86M COVID-exposed matched to 29.2M unexposed; median follow-up 2.4 years
- Sample size
- 42000000
- Category
- Public Health
- Maturity
- Validated
- Journal
- Diabetes, Obesity and Metabolism
Why it surfaced
Nation-scale (n=42M) linked EHR cohort provides high-powered, contextually definitive answer to a major epidemiological question. Reinforces that BMI, deprivation, and ethnicity outweigh COVID-19 as diabetes drivers — directly practice- and policy-relevant.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.